Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial.
Djavan B, Remzi M, Zlotta AR, Ravery V, Hammerer P, Reissigl A, Dobronski P, Kaisary A, Marberger M. Djavan B, et al. Among authors: kaisary a. Urology. 2002 Oct;60(4 Suppl 1):4-9. doi: 10.1016/s0090-4295(02)01896-4. Urology. 2002. PMID: 12384156
European Study of Radical Prostatectomy: time trends in Europe, 1993-2005.
Djavan B, Ravery V, Rocco B, Zlotta A, Brausi M, Margreiter M, Hammerer P, Kaisary A, Anagnostou T, Romics I, Dobronski P, De Cobelli O, Marberger M. Djavan B, et al. Among authors: kaisary a. BJU Int. 2007 Jul;100 Suppl 2:22-5. doi: 10.1111/j.1464-410X.2007.06948.x. BJU Int. 2007. PMID: 17594353 Review. No abstract available.
Effectiveness, pharmacokinetics, and safety of a new sustained-release leuprolide acetate 3.75-mg depot formulation for testosterone suppression in patients with prostate cancer: a Phase III, open-label, international multicenter study.
Marberger M, Kaisary AV, Shore ND, Karlin GS, Savulsky C, Mis R, Leuratti C, Germa JR. Marberger M, et al. Among authors: kaisary av. Clin Ther. 2010 Apr;32(4):744-57. doi: 10.1016/j.clinthera.2010.04.013. Clin Ther. 2010. PMID: 20435244 Clinical Trial.
Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years.
Iversen P, Tyrrell CJ, Kaisary AV, Anderson JB, Baert L, Tammela T, Chamberlain M, Carroll K, Gotting-Smith K, Blackledge GR. Iversen P, et al. Among authors: kaisary av. Urology. 1998 Mar;51(3):389-96. doi: 10.1016/s0090-4295(98)00004-1. Urology. 1998. PMID: 9510340 Clinical Trial.
92 results